Clinical Trial Update: A Phase 3 Study Comparing Carelizumab Plus Nab-paclitaxel and Apatinib, Carelizumab Plus Nab-paclitaxel, and Nab-paclitaxel in Patients With Advanced Triple Negative Breast Cancer. [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Carelizumab plus nab-paclitaxel with/apatinib, Carelizumab plus nab-paclitaxel, and nab-paclitaxel in advanced triple-negative breast ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Triple-negative Breast Cancer

Drugs mentioned

• Apatinib (apatinib)
• Carelizumab
• Nab-paclitaxel (paclitaxel protein-bound)

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Breast Cancer, Triple Negative Breast Cancer | Phase 3 | Status: TERMINATED